Accessibility: Skip TopNav
Graph 1
EndoPredict® Accurately Predicts Chemotherapy Benefit In Women with ER+, HER-Breast Cancer.
Format
PNG
Quelle:
Myriad Genetics, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein